{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:45:25Z","timestamp":1788432325737,"version":"build-2803163510"},"reference-count":178,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Dermatitis\u00ae"],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:p>\n                    <jats:bold>\n                      <jats:italic toggle=\"yes\">\n                        <jats:underline>Abstract:<\/jats:underline>\n                      <\/jats:italic>\n                    <\/jats:bold>\n                    Dupilumab, a monoclonal antibody targeting interleukin-4 antibody, is approved for use in many type 2 inflammatory diseases, including atopic dermatitis. It is generally well tolerated with no need of routine laboratory monitoring. However, several adverse events have been reported during real-world practice and in pivotal trials. We conducted a systematic literature research of the PubMed, Medline, and Embase databases to identify articles recording the clinical manifestation and potential pathogenesis of these adverse events with interests (AEIs) to dermatologists. In total, 547 cases from 134 studies have developed 39 AEIs 1 day to 2.5 years after dupilumab treatment. The most common AEIs are facial and neck dermatitis (299 cases), psoriasis (70 cases), arthralgia (56 cases), alopecia (21 cases), cutaneous T cell lymphoma (19 cases), severe ocular diseases (19 cases), and drug eruption (6 cases). Most of the AEIs recorded in this review resolved or improved after dupilumab discontinuation or the addition of another treatment, whereas 3 of the cases died of severe AEI. The potential pathogenesis included T help type 1 (Th1)\/T help type 2 (Th2) imbalance, Th2\/T help type 17 (Th17) imbalance, immune reconstitution, hypersensitivity reaction, transient hypereosinophilia related, and Th1 suppression. Clinicians should be alert of these AEIs for timely diagnosis and appropriate treatment.\n                  <\/jats:p>","DOI":"10.1089\/derm.2022.0096","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T14:55:25Z","timestamp":1684508125000},"page":"24-42","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":15,"title":["A Review of Dupilumab-Induced Adverse Events to Dermatologists and the Potential Pathogenesis in the Treatment of Atopic Dermatitis"],"prefix":"10.1177","volume":"35","author":[{"given":"Jun-Hong","family":"Tsai","sequence":"first","affiliation":[{"name":"From the,  Department of Medical Education, National Taiwan University Hospital, Taipei, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9565-3164","authenticated-orcid":false,"given":"Tsen-Fang","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, National Taiwan University Hospital &amp; National Taiwan University, College of Medicine, Taipei, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0768-3"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13491"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1700366"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-020-01379-9"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.08.018"},{"key":"e_1_3_1_7_2","first-page":"20","article-title":"Painless thyroiditis in a dupilumab-treated patient","volume":"2020","author":"Narantsatsral D","year":"2020","unstructured":"Narantsatsral D, , Junko T, , Hideyuki I, et al. Painless thyroiditis in a dupilumab-treated patient. Endocrinol Diabetes Metab Case Rep. 2020; 2020:20\u20130030.","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.5070\/D3264048364"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000001875"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.03.050"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/ced.15079"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.12788\/cutis.0074"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13880"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000679"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15501"},{"issue":"3","key":"e_1_3_1_16_2","first-page":"e15290","article-title":"Nodal anaplastic large cell lymphoma with lymphomatoid papulosis following treatment of initially presumed atopic dermatitis with dupilumab: a case report","volume":"35","author":"Amagai M","year":"2020","unstructured":"Amagai M, , Ozawa M, , Amagai R, et al. Nodal anaplastic large cell lymphoma with lymphomatoid papulosis following treatment of initially presumed atopic dermatitis with dupilumab: a case report. Dermatol Ther. 2020; 35(3):e15290.","journal-title":"Dermatol Ther"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.09.020"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-022-03330-y"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/cia2.12178"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.04.035"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15117"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/pde.14434"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v102.2245"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15807"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v102.1079"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16782"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13340-021-00526-1"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104763"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2022.01.009"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.07.003"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15740"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.0109"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1624683"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2020.12.6.1063"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-029520"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15471"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12762"},{"issue":"5","key":"e_1_3_1_38_2","first-page":"e15064","article-title":"Alcohol flushing during dupilumab therapy: an emerging adverse event","volume":"34","author":"Napolitano M","year":"2019","unstructured":"Napolitano M, , Potestio L, , Fabbrocini G, et al. Alcohol flushing during dupilumab therapy: an emerging adverse event. Dermatol Ther. 2019; 34(5):e15064.","journal-title":"Dermatol Ther"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13678"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.08.027"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1080\/01676830.2018.1553190"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.06.026"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.07.020"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2020.07.001"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16383"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.2871"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.03.070"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15871"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2021-0122"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18327"},{"key":"e_1_3_1_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14153"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.2613"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/pde.14499"},{"issue":"7","key":"e_1_3_1_54_2","first-page":"e27170","article-title":"Dupilumab-associated head and neck dermatitis with ocular involvement in a ten-year-old with atopic dermatitis: a case report and review of the literature","volume":"14","author":"Samia AM","year":"2022","unstructured":"Samia AM, , Cuervo-Pardo L, , Montanez-Wiscovich ME, et al. Dupilumab-associated head and neck dermatitis with ocular involvement in a ten-year-old with atopic dermatitis: a case report and review of the literature. Cureus. 2022; 14(7):e27170.","journal-title":"Cureus"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13898"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14888"},{"key":"e_1_3_1_57_2","doi-asserted-by":"publisher","DOI":"10.12788\/cutis.0316"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16322"},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16356"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-020-00458-6"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000785"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.5415\/apallergy.2022.12.e1"},{"key":"e_1_3_1_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14296"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15183"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000458"},{"key":"e_1_3_1_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14880"},{"key":"e_1_3_1_67_2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13023"},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000512"},{"key":"e_1_3_1_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2022.02.006"},{"key":"e_1_3_1_70_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3549"},{"key":"e_1_3_1_71_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16094"},{"key":"e_1_3_1_72_2","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0301"},{"key":"e_1_3_1_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2021.03.005"},{"key":"e_1_3_1_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2021.02.003"},{"key":"e_1_3_1_75_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16493"},{"key":"e_1_3_1_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.03.019"},{"key":"e_1_3_1_77_2","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2021.4063"},{"key":"e_1_3_1_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.11.012"},{"key":"e_1_3_1_79_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.3427"},{"key":"e_1_3_1_80_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1711010"},{"key":"e_1_3_1_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2017.06.017"},{"key":"e_1_3_1_82_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000002854"},{"key":"e_1_3_1_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2020.100848"},{"key":"e_1_3_1_84_2","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2020.1861305"},{"key":"e_1_3_1_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.11.002"},{"key":"e_1_3_1_86_2","first-page":"275","article-title":"Dupilumab induced limbal stem cell deficiency","volume":"14","author":"Mehta U","year":"2021","unstructured":"Mehta U, , Farid M. Dupilumab induced limbal stem cell deficiency. Int Med Case Rep J. 2021; 14:275\u2013278.","journal-title":"Int Med Case Rep J"},{"key":"e_1_3_1_87_2","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2021.4180"},{"key":"e_1_3_1_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.10.015"},{"key":"e_1_3_1_89_2","doi-asserted-by":"publisher","DOI":"10.1159\/000525738"},{"key":"e_1_3_1_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.05.013"},{"key":"e_1_3_1_91_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000824"},{"key":"e_1_3_1_92_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20064"},{"key":"e_1_3_1_93_2","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2021.4140"},{"key":"e_1_3_1_94_2","doi-asserted-by":"publisher","DOI":"10.1002\/cia2.12251"},{"key":"e_1_3_1_95_2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15345"},{"issue":"3","key":"e_1_3_1_96_2","first-page":"311","article-title":"Pustular psoriasis appearing induced by dupilumab therapy in a patient with atopic dermatitis","volume":"21","author":"Jia X","year":"2022","unstructured":"Jia X, , Li C, , Wu J, et al. Pustular psoriasis appearing induced by dupilumab therapy in a patient with atopic dermatitis. J Drugs Dermatol. 2022; 21(3):311\u2013312.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_1_97_2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15255"},{"key":"e_1_3_1_98_2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15399"},{"key":"e_1_3_1_99_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17050"},{"key":"e_1_3_1_100_2","doi-asserted-by":"publisher","DOI":"10.1111\/pde.14820"},{"key":"e_1_3_1_101_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000740"},{"key":"e_1_3_1_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.12.009"},{"key":"e_1_3_1_103_2","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13134"},{"key":"e_1_3_1_104_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18031"},{"key":"e_1_3_1_105_2","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14050"},{"key":"e_1_3_1_106_2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15872"},{"key":"e_1_3_1_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2022.01.036"},{"key":"e_1_3_1_108_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab771"},{"key":"e_1_3_1_109_2","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14984"},{"key":"e_1_3_1_110_2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15965"},{"key":"e_1_3_1_111_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.12.011"},{"key":"e_1_3_1_112_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16239"},{"key":"e_1_3_1_113_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-eular.1561"},{"key":"e_1_3_1_114_2","doi-asserted-by":"publisher","DOI":"10.1177\/2152656720927703"},{"key":"e_1_3_1_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2022.05.007"},{"key":"e_1_3_1_116_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-021-01803-8"},{"key":"e_1_3_1_117_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2021.08.415"},{"issue":"9","key":"e_1_3_1_118_2","first-page":"1248","article-title":"A case of progressive neuromuscular weakness following dupilumab administration","volume":"4","author":"Gochnauer B","year":"2021","unstructured":"Gochnauer B, , Narechania S, , Hilleman D, et al. A case of progressive neuromuscular weakness following dupilumab administration. J Am Coll Clin Pharm. 2021; 4(9):1248\u20131249.","journal-title":"J Am Coll Clin Pharm"},{"key":"e_1_3_1_119_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16218"},{"key":"e_1_3_1_120_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.881144"},{"key":"e_1_3_1_121_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20781"},{"key":"e_1_3_1_122_2","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v101.545"},{"key":"e_1_3_1_123_2","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0541"},{"key":"e_1_3_1_124_2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13854"},{"key":"e_1_3_1_125_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17264"},{"key":"e_1_3_1_126_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3734"},{"issue":"7","key":"e_1_3_1_127_2","first-page":"e16658","article-title":"An uncharacteristic presentation of Fe Syndrome following treatment with dupilumab","volume":"13","author":"Rutherford M","year":"2021","unstructured":"Rutherford M, , Tran M, , Salazar L, et al. An uncharacteristic presentation of Fe Syndrome following treatment with dupilumab. Cureus. 2021; 13(7):e16658.","journal-title":"Cureus"},{"key":"e_1_3_1_128_2","doi-asserted-by":"publisher","DOI":"10.14740\/jmc3336"},{"key":"e_1_3_1_129_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.10.024"},{"key":"e_1_3_1_130_2","doi-asserted-by":"publisher","DOI":"10.14309\/01.ajg.0000779552.97371.9e"},{"key":"e_1_3_1_131_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000651"},{"key":"e_1_3_1_132_2","doi-asserted-by":"publisher","DOI":"10.1111\/pde.14970"},{"issue":"221","key":"e_1_3_1_133_2","first-page":"19","article-title":"A case of tuberculous lymphadenitis in a severe atopic dermatitis patient treated with dupilumab","volume":"101","author":"Ahn J","year":"2021","unstructured":"Ahn J, , Lee DH, , Jang DH, et al. A case of tuberculous lymphadenitis in a severe atopic dermatitis patient treated with dupilumab. Acta Derm Venereol. 2021; 101(SUPPL 221):19.","journal-title":"Acta Derm Venereol"},{"key":"e_1_3_1_134_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15571"},{"key":"e_1_3_1_135_2","first-page":"9","article-title":"A case of dupilumab-induced eosinophilic pneumonia","volume":"203","author":"Adunse JU","year":"2021","unstructured":"Adunse JU, , Yoon Y, , Taleb M, et al. A case of dupilumab-induced eosinophilic pneumonia. Am J Respir Critic Care Med. 2021; 203:9.","journal-title":"Am J Respir Critic Care Med"},{"key":"e_1_3_1_136_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.09.022"},{"key":"e_1_3_1_137_2","doi-asserted-by":"publisher","DOI":"10.1111\/all.14964"},{"key":"e_1_3_1_138_2","first-page":"100821","article-title":"Eosinophilic vasculitis associated with persistent dupilumab-induced hypereosinophilia in severe asthma","volume":"79","author":"Descamps V","year":"2021","unstructured":"Descamps V, , Deschamps L, , El Khalifa J, et al. Eosinophilic vasculitis associated with persistent dupilumab-induced hypereosinophilia in severe asthma. Respir Med Res. 2021; 79:100821.","journal-title":"Respir Med Res"},{"issue":"5","key":"e_1_3_1_139_2","first-page":"e25218","article-title":"Exacerbation of eosinophilic granulomatosis with polyangiitis after administering dupilumab for severe asthma and eosinophilic rhinosinusitis with nasal polyposis","volume":"14","author":"Tanaka S","year":"2022","unstructured":"Tanaka S, , Tsuji T, , Shiotsu S, et al. Exacerbation of eosinophilic granulomatosis with polyangiitis after administering dupilumab for severe asthma and eosinophilic rhinosinusitis with nasal polyposis. Cureus. 2022; 14(5):e25218.","journal-title":"Cureus"},{"key":"e_1_3_1_140_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18049"},{"key":"e_1_3_1_141_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.141"},{"issue":"4","key":"e_1_3_1_142_2","first-page":"278","article-title":"Demodex musculi infestation in genetically immunomodulated mice","volume":"66","author":"Smith PC","year":"2016","unstructured":"Smith PC, , Zeiss CJ, , Beck AP, et al. Demodex musculi infestation in genetically immunomodulated mice. Comp Med. 2016; 66(4):278\u2013285.","journal-title":"Comp Med"},{"key":"e_1_3_1_143_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.03.009"},{"key":"e_1_3_1_144_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.02.044"},{"key":"e_1_3_1_145_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.194"},{"key":"e_1_3_1_146_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1416922112"},{"key":"e_1_3_1_147_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19459"},{"key":"e_1_3_1_148_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-eular.1363"},{"key":"e_1_3_1_149_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa568"},{"key":"e_1_3_1_150_2","doi-asserted-by":"publisher","DOI":"10.1002\/cia2.12289"},{"key":"e_1_3_1_151_2","doi-asserted-by":"publisher","DOI":"10.1111\/all.15071"},{"key":"e_1_3_1_152_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.02.1116"},{"key":"e_1_3_1_153_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413388"},{"key":"e_1_3_1_154_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.802036"},{"key":"e_1_3_1_155_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.09.029"},{"key":"e_1_3_1_156_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2022.02.002"},{"key":"e_1_3_1_157_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-020-00577-1"},{"key":"e_1_3_1_158_2","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2018.79445"},{"issue":"2","key":"e_1_3_1_159_2","first-page":"AB312","article-title":"Casale, Sarbjit S","volume":"149","author":"Marcus Maurer","year":"2022","unstructured":"Marcus Maurer, , Thomas B. Casale, Sarbjit S. Saini, et al. Dupilumab significantly reduces itch and hives in patients with chronic spontaneous urticaria: results from a phase 3 trial (LIBERTY-CSU CUPID Study A.). J Allergy Clin Immunol., 2022; 149(2):AB312.","journal-title":"Saini, et al. Dupilumab significantly reduces itch and hives in patients with chronic spontaneous urticaria: results from a phase 3 trial (LIBERTY-CSU CUPID Study A.). J Allergy Clin Immunol."},{"key":"e_1_3_1_160_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15755"},{"key":"e_1_3_1_161_2","doi-asserted-by":"publisher","DOI":"10.4414\/SMW.2021.w30020"},{"key":"e_1_3_1_162_2","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2018.1533567"},{"key":"e_1_3_1_163_2","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.9.3.29"},{"key":"e_1_3_1_164_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15608"},{"issue":"18","key":"e_1_3_1_165_2","first-page":"Supplement","article-title":"Hypersensitivity reaction following dupilumab injection due to excipient polysorbate-80","volume":"149","author":"Horisberger A","year":"2019","unstructured":"Horisberger A, , Di Lucca J, , Ribi C. Hypersensitivity reaction following dupilumab injection due to excipient polysorbate-80. Swiss Med Wkly. 2019; 149(18S\u201319S): Supplement 239.","journal-title":"Swiss Med Wkly"},{"key":"e_1_3_1_166_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.11.001"},{"key":"e_1_3_1_167_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.948358"},{"key":"e_1_3_1_168_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-64804-0_3"},{"key":"e_1_3_1_169_2","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12835"},{"key":"e_1_3_1_170_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2021.100003"},{"key":"e_1_3_1_171_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.05.019"},{"key":"e_1_3_1_172_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17177"},{"key":"e_1_3_1_173_2","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2022.2090342"},{"key":"e_1_3_1_174_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0702-4"},{"key":"e_1_3_1_175_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31881-1"},{"key":"e_1_3_1_176_2","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S207402"},{"key":"e_1_3_1_177_2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13404"},{"key":"e_1_3_1_178_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105518"},{"key":"e_1_3_1_179_2","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13448"}],"container-title":["Dermatitis\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/derm.2022.0096","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/derm.2022.0096","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/derm.2022.0096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:07:09Z","timestamp":1777399629000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/derm.2022.0096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":178,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2,1]]}},"alternative-id":["10.1089\/derm.2022.0096"],"URL":"https:\/\/doi.org\/10.1089\/derm.2022.0096","relation":{},"ISSN":["1710-3568","2162-5220"],"issn-type":[{"value":"1710-3568","type":"print"},{"value":"2162-5220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,24]]}}}